Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1–Survivin axis

BACKGROUND: High-grade glioma (HGG) is a fatal human cancer. Bortezomib, a proteasome inhibitor, has been approved for the treatment of multiple myeloma but its use in glioma awaits further investigation. This study aimed to explore the chemotherapeutic effect and the underlying mechanism of bortezo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Commun (Lond)
Main Authors: Tang, Jun-Hai, Yang, Lin, Chen, Ju-Xiang, Li, Qing-Rui, Zhu, Li-Rong, Xu, Qing-Fu, Huang, Guo-Hao, Zhang, Zuo-Xin, Xiang, Yan, Du, Lei, Zhou, Zheng, Lv, Sheng-Qing
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6892143/
https://ncbi.nlm.nih.gov/pubmed/31796105
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40880-019-0424-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados